One of the primary goals of the University of Michigan C.S. Mott Children’s Hospital Congenital Heart Center is to support research and innovation to drive improvements in quality of care and outcomes for children with heart disease.
The Michigan Congenital Heart Outcomes Research and Discovery (M-CHORD) Program, co-directed by Dr. Caren Goldberg and Dr. Sara Pasquali, supports research across the heart center. This unique program is composed of multi-disciplinary faculty members from pediatric cardiology, cardiac surgery, critical care, genetics, nephrology, and psychology, along with a dedicated staff of research nurses, study coordinators, database programmers and a biostatistician. M-CHORD’s work encompasses the full spectrum of clinical investigation, including translational research, clinical trials of new drugs and devices, long-term outcomes studies, and multicenter collaborative research examining best practices to improve outcomes and reduce resource utilization. Our aim is to push discoveries forward from the laboratory to the clinical setting, and to disseminate findings that will benefit children as quickly as possible.
Innovation and Device Development
The Michigan Congenital Heart Innovations Collaborative (M-CHIC) is a unique group of U-M Congenital Heart Center investigators, physicians, engineers, and other scientists across the University of Michigan focused on jumpstarting the development of innovative devices and therapies for congenital heart care.
Basic and Translational Research
The Congenital Heart Center at C.S. Mott Children's Hospital is committed to supporting basic and translational research as an important foundation for future breakthroughs in congenital heart care.